Latest Breaking News On - Europe venture fund - Page 1 : comparemela.com

AstriVax Awarded €3 Million Grant to Advance therapeutic Hepatitis B Vaccine

AstriVax Awarded €3 Million Grant to Advance therapeutic Hepatitis B Vaccine
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

BelgiumLeuvenRegion flamandeAckermans van haarenStefan klotterHanne callewaertKu leuven gemma frisius fundEurope venture fundFlanders innovationV bio venturesFlanders future techfundThuja capitalVenture fundEquity partnersFortis private equityLassen sie

AstriVax Awarded €2.5 Million Grant to Advance Innovative Vaccine Platform

AstriVax Awarded €2.5 Million Grant to Advance Innovative Vaccine Platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

LeuvenRegion flamandeBelgiumAckermans van haarenHanne callewaertAgentschap innoveren ondernemenEurope venture fundKu leuven gemma frisius fundFlanders innovationAgentschap innoverenFlemish governmentV bio venturesFlanders future techfundThuja capitalVenture fundEquity partners

AstriVax Awarded €2.5 Million Grant to Advance Innovative

The government grant is awarded by Flanders Innovation & Entrepreneurship (VLAIO).The grant will be used to accelerate the company’s vaccine platform..

BelgiumLeuvenRegion flamandeAckermans van haarenHanne callewaertAgentschap innoveren ondernemenKu leuven gemma frisius fundEurope venture fundFlanders innovationAgentschap innoverenFlemish governmentV bio venturesFlanders future techfundThuja capitalVenture fundEquity partners

AstriVax Receives €2.5M Grant

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

LeuvenRegion flamandeBelgiumAckermans van haarenHanne callewaertEurope venture fundKu leuven gemma frisius fundFlanders innovationV bio venturesFlanders future techfundThuja capitalVenture fundEquity partnersFortis private equityGemma frisius

AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development

Emmanuel Hanon, PhD, will chair the company's scientific advisory board. Professor Peter Piot (MD, PhD) and Professor Patrick Soentjens (MD, PhD) have been appointed as advisors. Together, they bring complementary

LeuvenRegion flamandeBelgiumBelgianPeter piotHanne callewaertEmmanuel hanonAckermans van haarenPatrick soentjenPatrick soentjensLondon school of hygiene tropical medicineNational immunization technical advisory groupKu leuven rega instituteGairdner award in global healthEurope venture fundEuropean commission